OR WAIT null SECS
June 29, 2023
Tower Cold Chain will soon open its new headquarters in Philadelphia.
This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release.
FDA approved Pfizer’s once-weekly human growth hormone analog for treatment of growth failure in pediatric patients.
The persistent poverty initiative aims to fight the cumulative effects of persistent poverty on cancer outcomes.
Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at approximately $1.7 billion.
June 27, 2023
The agency approved Elevidys to treat pediatric patients four through five years of age with Duchenne muscular dystrophy.
June 26, 2023
The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden.
The companies hope address the need for efficient collection, cryopreservation, quality control, and logistics capabilities of leukapheresis materials to support various aspects of the cell therapy workflow.
This collaboration is the first commercialization into the United States and Canadian markets for Rio Biopharmaceuticals.
The Segmentation by Exogenous Perfusion system uses a cell’s location in the tumor to find differences in gene activity.